APGE
Apogee Therapeutics

385
Mkt Cap
$5.2B
Volume
649,567.00
52W High
$77.09
52W Low
$26.20
PE Ratio
-17.61
APGE Fundamentals
Price
$77.08
Prev Close
$76.06
Open
$76.72
50D MA
$59.13
Beta
0.00
Avg. Volume
715,863.21
EPS (Annual)
-$3.30
P/B
9.44
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Apogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High - Should You Buy?
Apogee Therapeutics (NASDAQ:APGE) Reaches New 1-Year High - What's Next...
MarketBeat·3h ago
News Placeholder
More News
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High - Here's Why
Apogee Therapeutics (NASDAQ:APGE) Hits New 52-Week High - Should You Buy...
MarketBeat·3h ago
News Placeholder
Stempoint Capital LP Makes New Investment in Apogee Therapeutics Inc. $APGE
Stempoint Capital LP bought a new stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund...
MarketBeat·1d ago
News Placeholder
Apogee Therapeutics Inc. (NASDAQ:APGE) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the ten ratings firms that are presently covering the company...
MarketBeat·4d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) CEO Sells $3,000,400.00 in Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 40,000 shares of the company's stock in a transaction on Thursday, December 4th. The stock was sold at an...
MarketBeat·5d ago
News Placeholder
Carl Dambkowski Sells 10,900 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 10,900 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The shares were sold...
MarketBeat·5d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen downgraded Apogee Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·6d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Here's What Happened
Apogee Therapeutics (NASDAQ:APGE) Reaches New 1-Year High - Here's Why...
MarketBeat·7d ago
News Placeholder
Prudential Financial Inc. Has $2.99 Million Stake in Apogee Therapeutics Inc. $APGE
Prudential Financial Inc. increased its stake in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 176.4% in the 2nd quarter, according to the company in its most recent filing with the SEC...
MarketBeat·7d ago
News Placeholder
Franklin Resources Inc. Lowers Holdings in Apogee Therapeutics Inc. $APGE
Franklin Resources Inc. trimmed its stake in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 2.7% during the 2nd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·13d ago

Latest APGE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.